← Back to Search

In-Home Technology System for Dementia

N/A

Waitlist Available

Research Sponsored by University of California, Berkeley

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months to 6 months

Awards & highlights

Study Summary

This trial looks at a new technology designed to help reduce anxiety, stress, and loneliness for caregivers of people with Alzheimer's disease or other forms of dementia.

Eligible Conditions

Dementia
Mild Cognitive Impairment
Alzheimer's Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from 3 Months to 6 Months in Beck Anxiety Inventory (BAI)

Change from 3 Months to 6 Months in Center for Epidemiological Studies Depression Scale (CES-D)

Change from 3 Months to 6 Months in Revised Functional Limitations Battery

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: In-Home Technology SystemExperimental Treatment1 Intervention

The full system [(a) 1 gateway that connects with home internet to communicate/control the equipment; (b) 5 indoor motion sensors; (c) 3 door/cabinet entry sensors; (d) 1 water leak sensor; (e) 1 "call for help" button; (f) 2 motion-activated LED night lights; (g) 2 Vayyar fall detection and sleep quality sensors] will be self-installed by Spanish-speaking caregivers (N=60) in their homes. Monitoring of sensors, provision of warnings, messaging, and social networking features will be activated remotely for those participants who have been randomly assigned to this arm. Participation will extend over a 6 month period with questionnaires (e.g., health and well-being) administered 3 times (at the time of installation and every 3 months thereafter).

Group II: Limited In-Home Technology SystemPlacebo Group1 Intervention

The full system [(a) 1 gateway that connects with home internet to communicate/control the equipment; (b) 5 indoor motion sensors; (c) 3 door/cabinet entry sensors; (d) 1 water leak sensor; (e) 1 "call for help" button; (f) 2 motion-activated LED night lights; (g) 2 Vayyar fall detection and sleep quality sensors] will be self-installed by Spanish-speaking caregivers (N=60) in their homes. Only monitoring of the water leak sensor and associated warnings will be activated remotely for those participants who have been randomly assigned to this arm.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

In-Home Technology System

2022

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

People Power CompanyIndustry Sponsor

4 Previous Clinical Trials

534 Total Patients Enrolled

4 Trials studying Dementia

534 Patients Enrolled for Dementia

National Institute on Aging (NIA)NIH

1,669 Previous Clinical Trials

28,005,106 Total Patients Enrolled

265 Trials studying Dementia

23,623,403 Patients Enrolled for Dementia

University of California, San FranciscoOTHER

2,503 Previous Clinical Trials

15,236,647 Total Patients Enrolled

34 Trials studying Dementia

203,778 Patients Enrolled for Dementia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for willing participants in this clinical trial?

"Affirmative. According to clinicaltrials.gov, the initial posting of this medical trial was on September 1st 2022 and it is currently seeking participants. 120 patients need to be recruited from a single site for full data collection."

Answered by AI

How many subjects have been recruited for this research endeavor?

"Yes, the clinical trial is still recruiting as indicated by its presence on clinicaltrials.gov. This test was first published on September 1st 2022 and has since been updated to include a new cohort of 120 patients to be enrolled at one medical centre."

Answered by AI

Recent research and studies

Dementia and Geriatric Cognitive DisordersJournal

Greater Experience of Negative Non-target Emotions by Patients with Neurodegenerative Diseases Is Related to Lower Emotional Well-being in Caregivers

Chen, Kuan-Hua, Jenna L. Wells, Marcela C. Otero, Sandy J. Lwi, Claudia M. Haase, and Robert W. Levenson. 2017. “Greater Experience of Negative Non-target Emotions by Patients with Neurodegenerative Diseases Is Related to Lower Emotional Well-being in Caregivers”. Dementia and Geriatric Cognitive Disorders. S. Karger AG. doi:10.1159/000481132.

Proceedings of the National Academy of SciencesJournal

Poor Caregiver Mental Health Predicts Mortality of Patients with Neurodegenerative Disease

Lwi, Sandy J., Brett Q. Ford, James J. Casey, Bruce L. Miller, and Robert W. Levenson. 2017. “Poor Caregiver Mental Health Predicts Mortality of Patients with Neurodegenerative Disease”. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences. doi:10.1073/pnas.1701597114.

Dementia and Geriatric Cognitive DisordersJournal

Lower Visual Avoidance in Dementia Patients Is Associated with Greater Psychological Distress in Caregivers

Otero, Marcela C., and Robert W. Levenson. 2017. “Lower Visual Avoidance in Dementia Patients Is Associated with Greater Psychological Distress in Caregivers”. Dementia and Geriatric Cognitive Disorders. S. Karger AG. doi:10.1159/000468146.

The American Journal of Geriatric PsychiatryJournal